Summary Well-characterized cell lines established from primitive neuroectodermal tumours (PNETs) were examined by proton nuclear magnetic resonance ('H-NMR) spectroscopy and chromatographic analysis of perchloric acid extracts, following amplification in cell culture. A characteristic 'H-NMR spectroscopic metabolite pattern was found for medulloblastoma cell lines, which clearly discriminates these cells from PNETs of other locations in the central nervous system (CNS), on the basis of their N-acetyl aspartate (NM) and aspartate expression. Medulloblastoma cell lines were heterogeneous in respect of their metabolite expression, possibly owing to the heterogeneity in their differentiation along lineages of the CNS. All PNET spectra displayed similar features, including decreased NAA and creatine peaks and increased signals from choline compounds (Cho) compared with normal cerebellum. The expression of NM by the medulloblastoma lines was in the opposite order to the extent of neuronal differentiation, which may indicate their origin from a progenitor cell with the phenotype of an oligodendrocyte-type-2 astrocyte cell.
Primitive neuroectodermal tumours (PNETs) are highly malignant [grade IV according to the World Health Organization classification of brain tumours by Kleihues et al (1993) ] and among the most common tumours of childhood. They are most frequently located in the cerebellum (i.e. cerebellar medulloblastomas), but tumours that have a similar appearance and biological behaviour have been found in other locations in the central nervous system (CNS), such as the cerebrum, pineal region or spinal cord. The nature and cell of origin of these tumours, composed of primitive or undifferentiated neuroepithelial cells, is controversial. Questions have been raised as to whether their cell of origin is unique to the portion of the CNS in which the tumour arises, or whether there is a primitive or undifferentiated cell common to all portions of the CNS. Rorke et al (1985) have suggested that these tumours arise from a single primitive multipotential cell that has the capacity to differentiate into one or more types of neural cellssuch as astrocytes, oligodendrocytes, neurons, ganglion cells or melanocytes -and are therefore regarded as malignant counterparts of multipotential neural progenitor cells.
Progress in understanding the cell biology of these tumours has been hampered by the lack of cultured cell lines, since relatively few continuous medulloblastoma lines have been established thus far (Friedman et al, 1985; Jacobsen et al, 1985) . However, the recent establishment of five new human PNET cell lines from surgical specimens (Pietsch et al, 1994) offers the opportunity to investigate the biology, phenotype, lineage and metabolism of PNETs in detail. In the present study, metabolite profiles of several of these PNET cell lines in culture, together with two established cell lines, were obtained. Perchloric acid extracts from samples were analysed by proton nuclear magnetic resonance (1H-NMR) spectroscopy and high-performance liquid chromatography (HPLC) . The aim was to detect similarities or differences in the expression of specific metabolites by certain cell lines that could aid in elucidating the issues addressed above.
MATERIALS AND METHODS Preparation and analysis of cell cultures from human PNET cell lines
Some of the cell lines we examined were generated from PNETs of the cerebellum, i.e. from medulloblastomas: MHH-MED-1, MHH-MED-3, MHH-MED-4, D283-MED and DAOY. MHH-MED-3 and MHH-MED-4 were obtained from biopsies of cerebellar medulloblastomas, while MHH-MED-1 was generated from cells recovered from the cerebrospinal fluid of a patient with a recurrent cerebellar PNET that had seeded the cerebrospinal fluid. D283-MED and DAOY were lines previously established by Friedman et al (1985) and Jacobsen et al (1985) . Other cell lines (MHH-PNET-5 and MHH-PNET-6) were obtained from PNETs of other locations in the CNS. MHH-PNET-5 was obtained from a primary PNET located in the spinal cord, while MHH-PNET-6 was obtained from a PNET with disseminated growth in the CNS. *Present address: Huntsman Cancer Institute, University of Utah, Salt Lake City, UT 84112, USA The culture medium that was found to support efficiently the growth of medulloblastoma cell lines by Pietsch et al (1994) was Dulbecco's modified Eagle medium (DMEM), high-glucose formulation (Gibco BRL, Paisley, UK) supplemented with 4 mM Lglutamine (Sigma, Poole, UK) and 10% heat-inactivated, pretested human umbilical cord serum. The cultures were grown without antibiotics, and the culture medium was replaced every 3 days.
Protocols for cell harvesting, extraction and preparation of samples have been described previously in full by Florian et al (1995) . Brief details are given here. Starting with 106 cells from the stock for each individual cell line, cells were continuously carried in culture until the amount necessary for high-resolution NMR was obtained (typically 107-101 cells for a sample). Adherent cells (from D283-MED, DAOY and MHH-MED-4 cell lines) were harvested at 90-100% confluence. Cells growing in suspension were harvested in the exponential phase at a maximum density of 5x105 cells ml-', to avoid cells inhibiting each other. Harvesting for all cell lines was always performed 24 h after a final medium change, and cell pellets were immediately frozen in liquid nitrogen.
As cerebellum is the normal host tissue for the tumours examined, one sample of human cerebellum was also analysed. The difficulties in obtaining normal tissue from patients restricted us to this single sample. Adjacent tissue was obtained from the resection of a cerebellar vascular malformation from a 66-year-old female. The tissue was snap frozen within 30 s from removal. Immunocytochemical and histological analysis performed on the tissue have shown no abnormalities.
Perchloric acid (PCA) extracts were prepared from the frozen samples (cell pellets and frozen normal cerebellum). They were lyophilized and resuspended in D20 in order to obtain the NMR sample, to which an internal concentration and chemical shift standard was added. At least two PCA extracts were prepared for every individual cell line (replicate samples), except for the MHH-MED-3 line (one sample).
1H-NMR spectroscopy
Spectra were recorded at 26-300C on a Varian Unity-plus NMR spectrometer (Varian Associates, NMR Instruments, Palo Alto, CA, USA) operating at a proton frequency of 500 MHz. Singlepulse spectra (approaching full relaxation) were acquired with 450 pulses applied every 5 s, with presaturation of the residual water signal.
Metabolite peaks in IH-NMR spectra were identified by: (1) their chemical shift and coupling pattern as described in the literature by Cerdan et al (1985) , Sze et al (1990) and Preece et al (1993) ; (2) comparison with spectra of metabolites in known concentrations obtained at the same pH and spectroscopic conditions; (3) two-dimensional spectroscopic methods according to Florian et al (1995) . Metabolite amounts were calculated from their intensities in 'H-NMR spectra, by reference to the internal standard 3-trimethylsilyl-tetradeuterosodium propionate (TSP) after baseline correction. The intensity of a given signal in the proton spectrum is proportional to the concentration of the compound in the sample and to the number of protons contributing to each signal.
HPLC analysis of metabolites
Quantitative determination of amino acids, N-acetylaspartate (NAA) and N-acetylaspartylglutamate (NAAG) was performed by HPLC to complement the spectroscopic data, using methods that have already been described by Florian et al. (1995) . Amino acids were analysed by derivatization with O-phtaldialdehyde according to Lindroth and Mopper (1979) , the concentrations being calculated from external standards. NAA was analysed by a method previously described by Urenjak et al (1993) . Detection for NAAG was carried out using an Anachem SAX (46 mm internal diameter, 25 cm length) column fitted with a 1-cm guard column, according to Koller et al (1984) .
Data processing and statistics
The amounts of metabolites determined in each sample were referenced to the amount of protein in the sample [determined by the bicinchoninic acid method of Smith et al (1985) ], and they are expressed as nmol mg-' protein. The results from replicate samples of one to three extracts for a cell line were averaged for all cell lines considered within a category of tumour (i.e. lines derived from tumours of the cerebellum, MHH-MED and lines derived from PNETs of other locations in the CNS, MHH-PNET -see Results for more details). Results are presented as means±s.d.
One-way analysis of variance (ANOVA) was performed to determine significant differences among group means, and Pvalues are quoted without correction for multiple comparisons.
The critical values for assessing significance levels were obtained after performing a Bonferroni correction for multiple comparisons as described by Altman (1991) independently for NMR and HPLC data sets (10 and 12 comparisons respectively) from the cell line samples. These critical values are P<0.005 for a 5% significance level (i.e. 0.05/10 or 0.05/12), and P<0.001 for a 1% significance level (analogous).
RESULTS
The cell lines examined can be divided into two broad classes based on the location in the CNS of the original tumour, and of the morphological and immunocytochemical features of the cell line. One category (MHH-MED) includes tumours of the cerebellum (medulloblastomas): MHH-MED-1, MHH-MED-3, MHH-MED-4 and D283-MED. Another category (MHH-PNET) included PNETs of other locations in the CNS, MHH-PNET-5 and MHH-PNET-6. The DAOY medulloblastoma cell line was considered separately, as it has unusual growth characteristics and an atypical immunophenotype. Data from these cell lines were also compared with data from one sample of normal human cerebellum, although statistical analysis could not be performed on results from a single sample. Figure 1 shows representative spectra from each category of cell lines examined, and from the normal cerebellum. Quantitative data are given in Table 1 (from NMR spectra) and Tables 2 and 3 (HPLC determinations). (**1% level) aNMG amounts were considered 0 in the medulloblastoma cell lines (MHH-MED-3 and D283-MED) in which they were below the limit of detection by HPLC. ND, not detected (below the limit of detection). (Table 2 ). The highest amounts of this neuroactive amino acid were expressed by the cell lines MHH-MED-1 and D283-MED (Table 3) , while MHH-MED-4 cell line contained the lowest amount of GABA.
There were no statistically significant differences in the amounts of alanine between preparations from the cell lines examined, and the values for alanine concentration in tumours were similar to the value in normal cerebellum (both quantification from spectra and by HPLC, Tables 1 and 2 ). Spectra from all tumour cell lines displayed medium-intensity signals of threonine (1.3 p.p.m., doublet), as opposed to low threonine peaks in the spectrum from normal cerebellum.
DISCUSSION
Our analysis by 'H-NMR spectroscopy and HPLC of the metabolite composition of PNET-derived cell lines of the human CNS have yielded the finding that 'typical' medulloblastoma lines (derived from cerebellar tumours) differ in several respects from PNETs derived from outside the cerebellum. The clearest features were in the expression of NAA and aspartate.
The relationship between medulloblastomas of the cerebellum and PNETs of other regions in the CNS is controversial, owing to the still unresolved problem of histogenesis of the cerebellar medulloblastoma, as pointed out by Kleihues et al (1993) . The possibility that all PNETs arise from a single primitive multipotential cell population believed to be the subependymal layer, which has the capacity to differentiate into one or more types of neural cells, such as astrocytes, oligodendrocytes, neurons, ganglion cells or melanocytes, has been raised by Rorke et al (1985) . Further immunohistochemical and histological investigations performed by Cruz-Sanchez et al (1989) have demonstrated that differentiation in the medulloblastomas occurs along two lines: glial and/or neuronal. The observations of Burger et al (1987) and Cudkowitz and De la Monte (1989) suggest that the trend is predominantly towards neuronal rather than glial differentiation. The fact that medulloblastomas express neuronal but no glial-specific markers has been confirmed in studies on experimental mice PNETs of other locations in the CNS carried out by Fung et al (1994) .
Investigations by Trojanowski et al (1992 Trojanowski et al ( , 1994 have revealed that, in fact, neoplastic cells in PNETs exhibit molecular defects in the sequence of maturational events leading to the exit of stem cells or partially committed neuron-like precursors from the cell cycle, followed by their terminal differentiation into neurons, and therefore they partially recapitulate stages in the maturation of normal human CNS progenitor cells (neuroblasts).
In the context of these issues, the present study revealed a considerable heterogeneity in the expression of a number of metabolites across the medulloblastoma cell lines examined. This was in contrast to the relatively tight distribution of the corresponding metabolites (variation up to a factor of 5) reported by Florian et al (1996) in different cell lines comprising well-differentiated brain and nervous system tumours (either neuroblastomas, glioblastomas or meningiomas). An explanation for this may reside in the several degrees and directions of commitment in differentiation towards various lineages of the CNS of the medulloblastoma cells examined here. According to their immunophenotype, the lines studied represent various stages of neuronal differentiation, D283-MED being the most advanced. MHH-MED-3 has an 'early neuronal' phenotype, while MHH-MED-1 and MHH-MED-4 are rather undifferentiated (Pietsch et al, 1994 (C Florian, unpublished 
observations).
Among the cell lines studied, there were some that displayed detectable signals from NAA, a metabolite regarded as a neuronal marker (Gill et al, 1990; Urenjak et al, 1992) . The cell lines MHH-MED-4 and DAOY expressed the highest amounts of NAA, although, as shown by Pietsch et al (1994) , they lack features and markers (i.e. neurofilaments) of terminal neuronal commitment.
Within the category of cell lines derived from PNETs of the cerebellum (medulloblastomas) (excluding DAOY), the relative amounts of NAA in the cell lines that expressed it (MHH-MED-4>MHH-MED-l>MHH-MED-3>D283-MED) was in the opposite order to the extent of neuronal differentiation apparent from their immunophenotypic features (D283-MED>MEH-MED-3>MHH-MED-1 and MHH-MED-4) found by Pietsch et al (1994) . Although the number of replicates for each cell line was small, the NAA and GABA levels in a given cell line were reproducible, and we are confident they represent real differences rather than chance variations. Cell lines derived from PNETs of other locations in the CNS than cerebellum did not express NAA (undetectable in the NMR spectra and under the limit of detection by HPLC determinations). There does not seem to be any positive correlation between the presence of NAA in these lines revealed by the present study and the absence of advanced neuronal features or neuronal channels in these cell lines as suggested by other investigations (T Pietsch, unpublished observations) .
NAA was one of the key compounds in assigning cell lineage in our previous work, which has been found by Urenjak et al (1992) in significant concentrations in oligodendrocyte-type-2 astrocyte (0-2A) progenitor cells and in neurons. Additionally, Urenjak et al (1993) have found that the qualitative and quantitative differences between 'H-NMR spectra obtained from different purified populations of neural cells appears to be strongly correlated with the lineage of the cell type examined. In this respect, the higher levels of NAA found in less-differentiated PNETs and Miyake and Kakimoto (1981) and Bates et al (1989) , the relative contribution of the neuronal and 0-2A lineages to this rise is unclear. Therefore, it is not possible to say whether the NAA levels observed in PNET cell lines are typical of dividing neuronal progenitors of the cerebellum. There is a possibility that the expression of NAA by medulloblastomas reflects, in fact, their origin from a progenitor cell with the phenotypic characteristics of an 0-2A progenitor cell, rather than of a neuronal progenitor. Nonetheless, the highly significant differences in NAA levels between cerebellar medulloblastomas and PNETs from other CNS locations may suggest differences in lineage origin for these tumours, as well as differences from other tumours of the CNS, which have been studied by Florian et al (1995 Florian et al ( , 1996 .
A lack of correlation was also found in the expression of NAA and of GABA, and in the expression of GABA and the degree of neuronal differentiation by the medulloblastoma cell lines. Although high concentrations of the neuroactive amino acid GABA seem to be a specific attribute of neurons compared with other cell types of the brain as found by Urenjak et al (1993) , in the present study the highest concentrations of GABA were found in MHH-MED-I and D283-MED, whereas cell lines, such as MHH-MED-3 and -4, expressed the lowest amounts of GABA.
The above differences need to be recognized in the context of many similarities between the cell lines examined. Frahm et al (1990) and Bruhn et al (1989) . It is necessary to point out that, despite lineage specificity of NAA expression in CNS cells, there were unidentified common peaks found in IH-NMR spectra from the cell lines of both medulloblastomas and PNETs of other regions of the CNS. Until the metabolites have been identified that are responsible for generating these peaks, which cannot be accounted for by the culture medium, it is difficult to comment on their relevance to lineagespecific cell type recognition by 'H-NMR spectroscopy.
In conclusion, the results of this study suggest that medulloblastoma cell lines have a characteristic metabolite pattem detectable by 'H-NMR spectroscopy. This pattem discriminates cerebellar medulloblastomas from PNETs of other locations in the CNS, from normal cerebellum and from other brain tumours.
To our knowledge, this study is probably one of the first investigations by 'H-NMR spectroscopy on cell lines derived from human PNETs. No reference was found in the literature to studies using 'H-NMR spectroscopy on human PNETs, either in vivo or in vitro. The difficulties associated with studies in vitro such as this reside in establishing cell lines derived from specimens of PNETs, and in the maintenance and efficient continuous growth of such cell lines. Further studies on the metabolite profiles of fresh tumour samples from posterior fossa tumours of childhood of different degrees of differentiation and malignancy, such as pilocytic astrocytoma, haemangioblastoma, ependymoma, glioblastoma and medulloblastoma, will elucidate clinically the value of this method for these common childhood tumours, which represent a diagnostic problem before biopsy. In addition, we hope that it will be possible to develop an improved non-invasive NMR-based diagnostic tool in vivo, especially for tumours in locations in which biopsy is difficult and dangerous, such as brain stem tumours.
